A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

Keith J Horvath, Sara Lammert, Richard F Maclehose, Thu Danh, Jason V. Baker, Adam W. Carrico

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

Original languageEnglish (US)
Pages (from-to)3184-3198
Number of pages15
JournalAIDS and Behavior
Volume23
Issue number11
DOIs
StatePublished - Nov 1 2019

Keywords

  • Drug use
  • HIV/AIDS
  • Medication adherence
  • Mobile app

PubMed: MeSH publication types

  • Journal Article
  • Randomized Controlled Trial

Fingerprint Dive into the research topics of 'A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants'. Together they form a unique fingerprint.

  • Cite this